EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Cure Rate of COVID-19 Patients with Comorbid Hypertension

Made Widiantara Giri, I Made Subhawa Harsa

Nusantara Medical Science Journal · 06.12.2024 · 13-24

DOI: 10.20956/nmsj.vi.33144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nusantara Medical Science Journal, online erschienen am 06.12.2024. Verfasst von Made Widiantara Giri und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Coronavirus Disease 2019 (COVID-19) is an outbreak that has resulted in a global pandemic. In 2020, 185 countries were affected, and more than 3,000,000 cases have been reported worldwide, with more than 210,000 deaths. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2), an RNA virus that can cause respiratory system disorders. Hypertension, commonly called high blood pressure, is a health problem that often occurs in the community because its prevalence is relatively high throughout the world. Approximately 7.5 million deaths, or 12.8% of all annual deaths in the world, are caused by hypertension. Generally, the presence of comorbid hypertension in COVID-19 can worsen the patient's condition.

Methods

This literature review study aims to determine the recovery rate of COVID-19 patients with comorbid hypertension. Journals in this literature review used three databases, including Google Scholar, PubMed, and Science Direct, using the keywords COVID-19 with Hypertension and COVID-19 with Hypertension. The literature search was adjusted based on the inclusion and exclusion criteria.

Results

The search results obtained 25 journals consisting of 4 national journals and 21 international journals. The results showed that the average recovery rate for COVID-19 patients with comorbid hypertension was 75.40%. Factors influencing the recovery rate of COVID-19 patients with comorbid hypertension include ACE-2, ACEI/ARBs, age, male, and cytokines.

Conclusions

It can be concluded that the presence of comorbid hypertension affects the recovery rate of COVID-19 patients.

Zitieren

APA

Giri, M. W., & Harsa, I. M. S. (2024). The Cure Rate of COVID-19 Patients with Comorbid Hypertension. Nusantara Medical Science Journal, 13-24. https://doi.org/10.20956/nmsj.vi.33144

Vancouver

Giri MW, Harsa IMS. The Cure Rate of COVID-19 Patients with Comorbid Hypertension. Nusantara Medical Science Journal. 2024:13-24. doi:10.20956/nmsj.vi.33144

BibTeX
@article{Giri2024,
  author = {Giri, Made Widiantara and Harsa, I Made Subhawa},
  title = {The Cure Rate of COVID-19 Patients with Comorbid Hypertension},
  journal = {Nusantara Medical Science Journal},
  year = {2024},
  pages = {13--24},
  doi = {10.20956/nmsj.vi.33144}
}
Kostenlos starten →